IN2012DE00411A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00411A
IN2012DE00411A IN411DE2012A IN2012DE00411A IN 2012DE00411 A IN2012DE00411 A IN 2012DE00411A IN 411DE2012 A IN411DE2012 A IN 411DE2012A IN 2012DE00411 A IN2012DE00411 A IN 2012DE00411A
Authority
IN
India
Prior art keywords
peptides
protein
block
site
hemagglutinin
Prior art date
Application number
Other languages
English (en)
Inventor
Ashish
Kalpana Pandey
Yogendra Singh Rathore
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to US14/378,568 priority Critical patent/US9458196B2/en
Priority to PCT/IN2013/000094 priority patent/WO2013121441A2/en
Priority to EP13712604.1A priority patent/EP2814507A2/en
Priority to BR112014020153A priority patent/BR112014020153A2/pt
Priority to IN411DE2012 priority patent/IN2012DE00411A/en
Priority to CN201380019490.3A priority patent/CN104220091A/zh
Priority to ZA2014/05968A priority patent/ZA201405968B/en
Publication of IN2012DE00411A publication Critical patent/IN2012DE00411A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN411DE2012 2012-02-14 2013-02-14 IN2012DE00411A (pt)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US14/378,568 US9458196B2 (en) 2012-02-14 2013-02-14 Synthetic peptides capable of binding to influenza hemagglutinin protein
PCT/IN2013/000094 WO2013121441A2 (en) 2012-02-14 2013-02-14 Synthetic peptides capable of binding to influenza hemagglutinin protein
EP13712604.1A EP2814507A2 (en) 2012-02-14 2013-02-14 Synthetic peptides capable of binding to influenza hemagglutinin protein
BR112014020153A BR112014020153A2 (pt) 2012-02-14 2013-02-14 peptídeos sintéticos capazes de se ligarem à proteína hemaglutinina da influenza
IN411DE2012 IN2012DE00411A (pt) 2012-02-14 2013-02-14
CN201380019490.3A CN104220091A (zh) 2012-02-14 2013-02-14 能结合流感血细胞凝集素蛋白的合成肽
ZA2014/05968A ZA201405968B (en) 2012-02-14 2014-08-14 Synthetic peptides capable of binding to influenza hemagglutinin protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN411DE2012 IN2012DE00411A (pt) 2012-02-14 2013-02-14

Publications (1)

Publication Number Publication Date
IN2012DE00411A true IN2012DE00411A (pt) 2015-06-05

Family

ID=47998492

Family Applications (1)

Application Number Title Priority Date Filing Date
IN411DE2012 IN2012DE00411A (pt) 2012-02-14 2013-02-14

Country Status (7)

Country Link
US (1) US9458196B2 (pt)
EP (1) EP2814507A2 (pt)
CN (1) CN104220091A (pt)
BR (1) BR112014020153A2 (pt)
IN (1) IN2012DE00411A (pt)
WO (1) WO2013121441A2 (pt)
ZA (1) ZA201405968B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018170273A1 (en) * 2017-03-15 2018-09-20 University Of Washington De novo designed hemagglutinin binding proteins
CN107016257A (zh) * 2017-04-10 2017-08-04 湖北文理学院 一种基于saxs的蛋白质与表面活性剂复合物模型及解析方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258527B1 (en) * 1996-05-20 2001-07-10 The Aaron Diamond Aids Research Center Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof
US6337181B1 (en) * 1998-12-21 2002-01-08 Jeffrey Joseph Stewart Method of specifying vaccine components for viral quasispecies
US7951384B2 (en) 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
DE102005060920A1 (de) 2005-12-18 2007-06-21 Charité - Universitätsmedizin Berlin Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung
CA2649261A1 (en) 2006-03-13 2007-09-20 Keio University Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent
EP2096121A1 (en) * 2008-02-29 2009-09-02 Institut Pasteur Of Shanghai Antiviral peptides comprising lipid attachment signals and methods of use
US8475807B2 (en) * 2008-03-13 2013-07-02 University Of Maryland College Park Avian influenza virus live attenuated vaccine and uses thereof
FI20080333A0 (fi) 2008-05-02 2008-05-02 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
EP2391748A4 (en) 2009-01-28 2012-08-01 Antigen Express Inc LI-KEY HYBRID PEPTIDES MODULATING IMMUNE RESPONSE TO FLU
US20120014972A1 (en) 2010-01-26 2012-01-19 The Regents Of The University Of Colorado, A Body Corporate Influenza virus compositions and methods for universal vaccines

Also Published As

Publication number Publication date
WO2013121441A3 (en) 2013-10-10
US9458196B2 (en) 2016-10-04
ZA201405968B (en) 2016-10-26
BR112014020153A2 (pt) 2017-07-04
EP2814507A2 (en) 2014-12-24
WO2013121441A2 (en) 2013-08-22
CN104220091A (zh) 2014-12-17
US20150071952A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
HK1210055A1 (en) Fusion polypeptides comprising an active protein linked to a mucin- domain polypeptide
ZA201505054B (en) Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
BR112015001327A2 (pt) complexo cristalino de 1-ciano-2-(4-ciclopropil-benzil) -4-(beta-d-glicopiranos-1-il) -benzeno, métodos para sua preparação e o uso do mesmo para preparar medicamentos
IN2014KN03063A (pt)
IL230463A (en) Benzamides, their preparation and their pharmaceutical preparations
HK1200848A1 (en) Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
BR112015012380A2 (pt) vírus influenza recombinante
HK1250743A1 (zh) 表達載體組織、新的生產用細胞產生方法及其在重組產生多肽中的用途
MX2017008406A (es) Conjugados de aminoacidos y peptidos y sus usos.
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
EA201590860A1 (ru) Варианты гемагглютинина и нейраминидазы вируса свиного гриппа
TR201100150A2 (tr) Suda çözünür dozaj formları
IN2012DE00411A (pt)
CO6831986A2 (es) Composición farmacéutica que comprende fexofenadina
EP2827896A4 (en) STABLE MIETIC PEPTIDES FROM HIV-1 GP41 PRE-PILLING HAIRPROOF INTERMEDIATE
BR112013023859A2 (pt) moléculas conjugadas compreendendo um peptídeo derivado do receptor cd4 acoplado a um polipeptídeo polianiônico para o tratamento da aids
MX2015009077A (es) Composicion estable que contiene fingolimod.
CY1120767T1 (el) Συνθεσεις glp-1 πεπτιδιων και παρασκευη αυτων
IL261409A (en) Methods and compositions for production of recombinant pharmaceutical proteins in medicinal plants
PL398414A1 (pl) Zastosowanie kwas fenylo-1,4-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
PL398411A1 (pl) Zastosowanie kwasu naftylo-1,5-diaminobis(metylidenobisfosfonowego) w preparacie farmaceutycznym
ECSP14024494A (es) Anticuerpos frente a los Ligandos del receptor B1 de bradicinina
PL399720A1 (pl) Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego
PL398409A1 (pl) Zastosowanie kwasów bifenylo-4,4'-diaminobis(metylidenobisfosfonowych) do wytwarzania preparatu farmaceutycznego
CO6470851A2 (es) Nuevas sales farmaceuticamente aceptables de 4-(1h-imidazol-4-ilmetil)piridina y sus usos terapeuticos